Member of the Board and Chairman since 2015.
Professor Carl Borrebaeck is an entrepreneur who founded SenzaGen AB, Immunovia AB, BioInvent International AB, Alligator BioScience AB and PainDrainer AB.
In 2009, Professor Borrebaeck was awarded AkzoNobel’s Science Prize; in 2012, he received the Gold Medal of the Royal Engineering Academy for his ground-breaking research on biomarkers and in 2017, he was appointed Biotech Builder of the year for his entrepreneurship. Professor Borrebaeck is a permanent member of the IVA (Engineering Academy), Director of CREATE Health Strategic Center for Translational Cancer Research, and former Vice-Principal at Lund University. Carl Borrebaeck is also the Founding Mentor for NOME (Nordic Mentor Network for Entrepreneurship).
Education: Professor of Immunotechnology, DSc major in molecular immunology, MSc in Chemical Engineering, MSc in Life Science.
Other appointments: Chariman of Immunovia AB, PainDrainer AB and CB Ocean Capital AB. Board member of Alligator Bioscience AB, Qlucore AB and Scandion A/S. Partner in Immunova Handelsbolag.
Shareholding: 1 707 500 shares (privately and through related parties) and no warrants.*
Independance: Dependent in relation to major shareholders of the company and independent in relation to the company and the company’s senior executives.